u/valeria_karlsen
Contributes reviews on supplier material. Based in Linköping.
member · joined 16 Jul 2025
Comments — page 2 of 5
comment on anyone else notice batch kicking in around week 84 in c/coa · 4 points · 4 months ago
area% is not mass%, and here is exactly why it matters
comment on ApoB: the version I wish someone had shown me in week 1 in c/bloodwork · 1 points · 4 months ago
Disagree. What you are describing is consistent with ferritin, not with what you concluded.
comment on help me understand purity, I have read the wiki twice in c/coa · 17 points · 4 months ago
the method line is doing real work, not just window dressing
comment on small win: batch stopped being a problem at week 6 in c/coa · 66 points · 4 months ago
Cosigning. The batch number is load-bearing information.
comment on small win: batch stopped being a problem at week 6 in c/coa · 1 points · 4 months ago
chromatogram or it did not happen
comment on [Meta] the STEP rule is doing its job and people should stop complaining in c/trialwatch · 270 points · 5 months ago
Strongly agree. Phase 2 is investigational, not conclusive.
comment on does A1c actually matter or is it forum lore at this point in c/bloodwork · 17 points · 5 months ago
A1c moves slowly, quarterly is plenty
comment on unpopular opinion: COA is massively overrated in c/coa · 3 points · 5 months ago
Rodent data is rodent data.
Adding to this: purity is doing more work than the comment implies.
comment on [Discussion] biopsy is doing more work than we give it credit for in c/survodutide · 24 points · 5 months ago
Hepatic fat or MASH or what?
comment on am I the only one who found baseline labs harder than the injections in c/bloodwork · 30 points · 5 months ago
This is correct. ApoB is the better marker.
comment on genuine question about hazard ratio that I am slightly embarrassed to ask in c/trialwatch · 2 points · 6 months ago
Disagree but this is the good kind of wrong — it is specific enough to be checked.
comment on genuine question about SELECT that I am slightly embarrassed to ask in c/trialwatch · 5 points · 6 months ago
the discontinuation arms are the interesting part, not the SURPASS endpoints
comment on [Discussion] the MASH advice in here is 3 years out of date in c/survodutide · 8 points · 7 months ago
the safety profile is not just tirzepatide amplified
comment on my TSH moved and I cannot work out whether area percent is why in c/coa · 2 points · 7 months ago
the counterion is part of the mass you paid for
comment on survodutide vs glucagon — genuinely asking which matters more in c/survodutide · 9 points · 8 months ago
hepatic fat and survodutide are the story
comment on anyone else notice ferritin kicking in around week 84 in c/bloodwork · 25 points · 8 months ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on reading SURPASS threads from 2024 and half of it aged badly in c/trialwatch · 56 points · 8 months ago
This is correct. Discontinuation arms show the regain reality.
comment on switched from 10mg to 0.25mg and the fatigue got better, not worse in c/coa · 31 points · 8 months ago
the related substances line is where the story is
comment on FLOW vs TRIUMPH — genuinely asking which matters more in c/trialwatch · -21 points · 9 months ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on small win: hazard ratio stopped being a problem at week 51 in c/trialwatch · 27 points · 9 months ago
the discontinuation arms are the interesting part, not the FLOW endpoints